Oculus Innovative Sciences (OCLS) Tops Q2 EPS by 14c

Oculus Innovative Sciences (NASDAQ: OCLS) reported Q2 EPS of ($0.11), $0.14 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.98 million versus the consensus estimate of $3.12 million.

For earnings history and earnings-related data on Oculus Innovative Sciences (OCLS) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c